27 results on '"Shakya, Geeta"'
Search Results
2. Changing epidemiology and antimicrobial resistance in Vibrio cholerae: AMR surveillance findings (2006–2016) from Nepal
- Author
-
Rijal, Nisha, Acharya, Jyoti, Adhikari, Shailaja, Upadhaya, Bishnu Psd, Shakya, Geeta, Kansakar, Palpasa, and Rajbhandari, Piyush
- Published
- 2019
- Full Text
- View/download PDF
3. Prevalence of chronic hepatitis B virus infection before and after implementation of a hepatitis B vaccination program among children in Nepal
- Author
-
Upreti, Shyam Raj, Gurung, Santosh, Patel, Minal, Dixit, Sameer M., Krause, L. Kendall, Shakya, Geeta, Wannemuehler, Kathleen, Rajbhandari, Rajesh, Bohara, Rajendra, and Schluter, W. William
- Published
- 2014
- Full Text
- View/download PDF
4. Strengthening laboratory surveillance of antimicrobial resistance in South East Asia: Antimicrobial Resistance in South East Asia
- Author
-
Shah, Aparna Singh, Karunaratne, Kumudu, Shakya, Geeta, Barreto, Ismael, Khare, Shashi, Paveenkittiporn, Wantana, Wangchuk, Sonam, Tin, Htay Htay, Muhsin, Milza Abdul, Aung, Lin, Bhatia, Rajesh, Srivastava, Rahul, and Maryandi, Dwi Adi
- Published
- 2017
- Full Text
- View/download PDF
5. Developing Rubella Vaccination Policy in Nepal—Results From Rubella Surveillance and Seroprevalence and Congenital Rubella Syndrome Studies
- Author
-
Upreti, Shyam Raj, Thapa, Kusum, Pradhan, Yasho Vardan, Shakya, Geeta, Sapkota, Yuddha Dhoj, Anand, Abhijeet, Taylor, Thomas, Mach, Ondrej, Reef, Susan, Pattamadilok, Sirima, Liyanage, Jayantha, O'Connor, Patrick, Sedai, Tika, Bhandary, Sagar Ram, Partridge, Jeffrey, and Schluter, William
- Published
- 2011
- Full Text
- View/download PDF
6. Phenotypic and genetic characterization of Vibrio cholerae O1 clinical isolates collected through national antimicrobial resistance surveillance network in Nepal
- Author
-
Shakya, Geeta, Kim, Dong Wook, Clemens, John D., Malla, Sarala, Upadhyaya, Bishnu Prasad, Dumre, Shyam Prakash, Shrestha, Sirjana Devi, Adhikari, Shailaja, Sharma, Supriya, Rijal, Nisha, Shrestha, Sanjaya K., Mason, Carl, and Kansakar, Palpasa
- Published
- 2012
- Full Text
- View/download PDF
7. Low population Japanese encephalitis virus (JEV) seroprevalence in Udayapur district, Nepal, three years after a JE vaccination programme: A case for further catch up campaigns?
- Author
-
Turtle, Lance, Brindle, Hannah E., Schluter, W. William, Faragher, Brian, Rayamajhi, Ajit, Bohara, Rajendra, Gurung, Santosh, Shakya, Geeta, Yoksan, Sutee, Dixit, Sameer, Rajbhandari, Rajesh, Paudel, Bimal, Adhikari, Shailaja, Solomon, Tom, and Griffiths, Mike J.
- Subjects
Adult ,Male ,wa_115 ,viruses ,Enzyme-Linked Immunosorbent Assay ,wa_395 ,Viral Plaque Assay ,Antibodies, Viral ,wc_500 ,Young Adult ,Nepal ,Neutralization Tests ,Seroepidemiologic Studies ,Surveys and Questionnaires ,Humans ,Encephalitis, Japanese ,Aged ,Aged, 80 and over ,Encephalitis Virus, Japanese ,Immunization Programs ,Japanese Encephalitis Vaccines ,Dengue Virus ,Middle Aged ,Antibodies, Neutralizing ,Cross-Sectional Studies ,Immunoglobulin M ,Immunoglobulin G ,qw_160 ,Female ,Research Article - Abstract
The live attenuated Japanese encephalitis (JE) vaccine SA14-14-2 has been used in Nepal for catch-up campaigns and is now included in the routine immunisation schedule. Previous studies have shown good vaccine efficacy after one dose in districts with a high incidence of JE. The first well-documented dengue outbreak occurred in Nepal in 2006 with ongoing cases now thought to be secondary to migration from India. Previous infection with dengue virus (DENV) partially protects against JE and might also influence serum neutralising antibody titres against JEV. This study aimed to determine whether serum anti-JEV neutralisation titres are: 1. maintained over time since vaccination, 2. vary with historic local JE incidence, and 3. are associated with DENV neutralising antibody levels. We conducted a cross-sectional study in three districts of Nepal: Banke, Rupandehi and Udayapur. Udayapur district had been vaccinated against JE most recently (2009), but had been the focus of only one campaign, compared with two in Banke and three in Rupandehi. Participants answered a short questionnaire and serum was assayed for anti-JEV and anti-DENV IgM and IgG (by ELISA) and 50% plaque reduction neutralisation titres (PRNT(50)) against JEV and DENV serotypes 1–4. A titre of ≥1:10 was considered seropositive to the respective virus. JEV neutralising antibody seroprevalence (PRNT(50) ≥ 1:10) was 81% in Banke and Rupandehi, but only 41% in Udayapur, despite this district being vaccinated more recently. Sensitivity of ELISA for both anti-JEV and anti-DENV antibodies was low compared with PRNT(50.) DENV neutralising antibody correlated with the JEV PRNT(50) ≥1:10, though the effect was modest. IgM (indicating recent infection) against both viruses was detected in a small number of participants. We also show that DENV IgM is present in Nepali subjects who have not travelled to India, suggesting that DENV may have become established in Nepal. We therefore propose that further JE vaccine campaigns should be considered in Udayapur district, and similar areas that have had fewer vaccination campaigns.
- Published
- 2019
8. Outbreak of pandemic influenza A/H1N1 2009 in Nepal
- Author
-
Shrestha Sirjana, Prakash KC Khagendra, Upadhyay Bishnu, Shakya Geeta, Adhikari Bal Ram, and Dhungana Guna
- Subjects
Infectious and parasitic diseases ,RC109-216 - Abstract
Abstract Background The 2009 flu pandemic is a global outbreak of a new strain of H1N1 influenza virus. Pandemic influenza A (H1N1) 2009 has posed a serious public health challenge world-wide. Nepal has started Laboratory diagnosis of Pandemic influenza A/H1N1 from mid June 2009 though active screening of febrile travellers with respiratory symptoms was started from April 27, 2009. Results Out of 609 collected samples, 302 (49.6%) were Universal Influenza A positive. Among the influenza A positive samples, 172(28.3%) were positive for Pandemic influenza A/H1N1 and 130 (21.3%) were Seasonal influenza A. Most of the pandemic cases (53%) were found among young people with ≤ 20 years. Case Fatality Ratio for Pandemic influenza A/H1N1 in Nepal was 1.74%. Upon Molecular characterization, all the isolated pandemic influenza A/H1N1 2009 virus found in Nepal were antigenically and genetically related to the novel influenza A/CALIFORNIA/07/2009-LIKE (H1N1)v type. Conclusion The Pandemic 2009 influenza virus found in Nepal were antigenically and genetically related to the novel A/CALIFORNIA/07/2009-LIKE (H1N1)v type.
- Published
- 2011
- Full Text
- View/download PDF
9. Feasibility of a Comprehensive Targeted Cholera Intervention in The Kathmandu Valley, Nepal.
- Author
-
Roskosky, Mellisa, Acharya, Bhim, Shakya, Geeta, Karki, Kshitij, Sekine, Kazutaka, Bajracharya, Deepak, von Seidlein, Lorenz, Devaux, Isabelle, Lopez, Anna Lena, Deen, Jacqueline, and Sack, David A.
- Published
- 2019
- Full Text
- View/download PDF
10. Outbreak Investigation Following the 2015 Earthquake Disaster in Nepal.
- Author
-
Shakya, Geeta, Marasini, Baburam, Karki, Khem Bahadur, Upadhaya, Bishnu Prasad, Acharya, Jyoti, Adhikari, Shailaja, Manjhi, Rosham, Maharjan, Laxman, Shrestha, Lilee, Ranabhat, Kamal, Marahatta, Sujan Babu, Shrestha, Bikal, and Dhimal, Meghnath
- Published
- 2018
- Full Text
- View/download PDF
11. Dengue Virus Serotypes 1 and 2 Responsible for Major Dengue Outbreaks in Nepal: Clinical, Laboratory, and Epidemiological Features.
- Author
-
Dumre, Shyam Prakash, Bhandari, Renu, Shakya, Geeta, Shrestha, Sanjaya Kumar, Cherif, Mahamoud Sama, Ghimire, Prakash, Chonticha Klungthong, In-Kyu Yoon, Kenji Hirayama, Kesara Na-Bangchang, and Fernandez, Stefan
- Published
- 2017
- Full Text
- View/download PDF
12. Characterization of influenza A(H1N1)pdm09 viruses isolated from Nepalese and Indian outbreak patients in early 2015.
- Author
-
Nakamura, Kazuya, Shirakura, Masayuki, Fujisaki, Seiichiro, Kishida, Noriko, Burke, David F., Smith, Derek J., Kuwahara, Tomoko, Takashita, Emi, Takayama, Ikuyo, Nakauchi, Mina, Chadha, Mandeep, Potdar, Varsha, Bhushan, Arvind, Upadhyay, Bishnu Prasad, Shakya, Geeta, Odagiri, Takato, Kageyama, Tsutomu, and Watanabe, Shinji
- Subjects
INFLUENZA A virus ,DISEASE outbreaks ,VIRUS diseases ,HEMAGGLUTININ ,PUBLIC health surveillance ,PUBLIC health - Abstract
We characterized influenza A(H1N1)pdm09 isolates from large-scale outbreaks that occurred in Nepal and India in early 2015. Although no specific viral features, which may have caused the outbreaks, were identified, an S84N substitution in hemagglutinin was frequently observed. Chronological phylogenetic analysis revealed that these Nepalese and Indian viruses possessing the S84N substitution constitute potential ancestors of the novel genetic subclade 6B.1 virus that spread globally in the following (2015/16) influenza season. Thus, active surveillance of circulating influenza viruses in the Southern Asia region, including Nepal and India, would be beneficial for detecting novel variant viruses prior to their worldwide spread. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
13. Shigellosis in Nepal: 13 years review of nationwide surveillance.
- Author
-
Shakya, Geeta, Acharya, Jyoti, Adhikari, Shailaja, and Rijal, Nisha
- Subjects
- *
SHIGELLOSIS , *ANTI-infective agents , *SURVEILLANCE detection , *PUBLIC health , *DIAGNOSIS , *THERAPEUTICS - Abstract
Background: Shigella is a major cause of gastroenteritis especially in children. In developing countries, the incidence is frequent and results are often life threatening. Changing epidemiology and emerging antibiotic resistance warrants continuous monitoring of susceptibility. The present study highlights the changing epidemiology and drug resistance patterns of Shigella isolated at different hospitals of Nepal over a period of 13 years (Jan. 2003-Dec. 2015). Methods: This study was carried out in 12 participating laboratories. Stool specimens received at respective laboratories were processed for isolation and identification of Shigella species and confirmed by serotyping at National Public Health Laboratory. Antimicrobial resistance patterns were determined by Kirby Baeur disc diffusion test. Results: A total of 332 isolates were identified as Shigella species of which Shigella flexneri (50 %) was the predominant serotype. Shigella dysenteriae, Shigella sonnei, Shigella boydii, and untypable Shigella spp. respectively, accounted for 28.6, 27.54, 10.2, 4.5, and 6.6 % of the total number. Change in prevalent serotype is noted over the years. S. dysenteriae was the prevalent species in Nepal in 2003 and 2004, but since 2005, S. flexneri remained prevalent. Majority of the isolates were recovered from children aged 1-10 years and was statistically significant (p = 0.023) compared to the other age groups. High resistance among all Shigella species to the first-line drugs like ampicillin (88 %), cotrimoxazole (76 %), ciprofloxacin (39 %,) and nalidixic acid (80 %) was observed; 46.1 % of total isolates were multidrug resistant (MDR), and the most common MDR profile was ampicillin, nalidixic acid, and co-trimoxazole. Prevalence of MDR increased significantly in 2010 as compared to 2003. Only few Shigella isolates were resistant to ceftriaxone. Conclusions: The study revealed S. flexneri as the predominant serogroup in Nepal. Children below 10 years were more prone to the disease. Nalidixic acid, ampicillin, co-trimoxazole, and ciprofloxacin should not be used empirically as the first-line drugs in treatment of shigellosis. Since the distribution of different species of Shigella and their antibiotic susceptibility profile may vary from one geographical location to another and may also change with time, continuous local monitoring of resistance patterns is necessary for appropriate antimicrobial therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
14. Outbreak Investigation of Influenza in Pazaru VDC of Jajarkot District of Nepal.
- Author
-
Upadhyaya, Shambhu Kumar, Pradhan, Pranil Man Singh, Mahato, Raj Kumar, Marasini, Baburam, Upadhyaya, Bishnu, Shakya, Geeta, Baral, Gehanath, and Baral, Kedar Prasad
- Published
- 2016
15. Evaluation of SD Bioline HIV/syphilis Duo rapid test kits in Nepal.
- Author
-
Shakya, Geeta, Singh, Dipendra Raman, Ojha, Hemanta Chandra, Ojha, Chet Raj, Mishra, Shravan Kumar, Malla, Karishma, Chaudhary, Puspa, and Regmi, Kiran
- Subjects
- *
SYPHILIS , *DIAGNOSIS of HIV infections , *HIV infection transmission , *OBSTETRICIANS , *PUBLIC health , *COMMUNICABLE disease diagnosis , *PREGNANCY complications , *DIAGNOSIS of syphilis , *MIXED infections , *CLINICAL trials , *COMPARATIVE studies , *DIAGNOSTIC reagents & test kits , *LONGITUDINAL method , *RESEARCH methodology , *MEDICAL cooperation , *RESEARCH , *EVALUATION research , *CROSS-sectional method , *DIAGNOSIS - Abstract
Background: Accurate and prompt diagnosis of HIV and syphilis simultaneously has reinforcing effect on their control program because of their prevalent co-infection. Availability of a simple user-friendly two-pronged and affordable detection tools brings down the cost of health care. They are important in the antenatal clinics, with added opportunity for intervention and prevention of mother to child transmission. In cooperation with rapid test kit manufacturers, SD Bioline, NPHL and NCASC, an evaluation of commercially available HIV/syphilis Duo rapid test kit (SD Bioline) to assess its performance and operational characteristics was done in the present study.Method: A prospective laboratory-based cross sectional study was conducted at a large Women's Hospital. Ten thousand pregnant women, visiting the Hospital for antenatal care or for delivery, were enrolled in study. Tests were performed by the SD Bioline HIV/Syphilis Duo kit as well as national algorithm for HIV and syphilis diagnosis which were considered gold standard. Sensitivity, Specificity, positive predictive value and negative predictive value along with kappa coefficient were calculated for the kit under evaluation.Result: The sensitivity, specificity, Negative predictive value and Positive predictive value of the kit for HIV diagnosis were 100 % (95 % CI 83.18-100 %, 99.96-100 %, 83.18-100 %, and 99.96-100 %, respectively). Kappa value was found to be 1.0. Out of total cases, results of 9985 (99.85 %) cases were concordant with National algorithm for syphilis diagnosis. Thirteen (0.13 %) cases were found false positive while two were false negative. The sensitivity of the kit for syphilis diagnosis was found to be 95.45 % (95 % CI 84.86-98.74 %) and specificity was 99.87 % (95 % CI; 99.78-99.92 %). Positive predictive value was 76.36 % (95 % CI; 63.65-85.63 %) and Negative predictive value was 99.89 % (95 % CI; 99.39-99.99 %). Kappa value was found to be 0.85.Conclusion: The performance characteristics of SD Bioline HIV/Syphilis duo kit were found almost concordant with the kits being used for HIV and Syphilis diagnosis separately. Its implementation in antenatal clinics/VCTs could be an added opportunity for simultaneous diagnosis of HIV and syphilis. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
16. Virological and Immunological Status of the People Living with HIV/AIDS Undergoing ART Treatment in Nepal.
- Author
-
Ojha, Chet Raj, Shakya, Geeta, and Dumre, Shyam Prakash
- Subjects
- *
AGE distribution , *ANALYSIS of variance , *CHI-squared test , *CONFIDENCE intervals , *STATISTICAL correlation , *FLOW cytometry , *HIV infections , *RESEARCH methodology , *MEDICAL cooperation , *POLYMERASE chain reaction , *QUESTIONNAIRES , *RESEARCH , *VIRAL load , *CROSS-sectional method , *LAMIVUDINE , *DATA analysis software , *TENOFOVIR , *ANTI-HIV agents , *DESCRIPTIVE statistics , *EFAVIRENZ , *CD4 lymphocyte count - Abstract
Antiretroviral therapy (ART) has increased the life span of the people living with HIV (PLHIV), but their virological and immunological outcomes are not well documented in Nepal. The study was conducted at a tertiary care center including 826 HIV-1 seropositive individuals undergoing ART for at least six months. Plasma viral load (HIV-1 RNA) was detected by Real Time PCR and CD4+ T-lymphocyte (CD4+) counts were estimated by flow cytometry. The mean CD4+ count of patients was 501 (95% CI = 325–579) cells/cumm, but about 35% of patients had CD4+ T cell counts below 350 cells/cumm. With increasing age, average CD4+ count was found to be decreasing (p=0.005). Of the total cases, 82 (9.92%) were found to have virological failure (viral load: >1000 copies/ml). Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV), the frequently used ART regimen in Nepal, showed virological failure in 11.34% and immunological failure in 37.17% of patients. Virological failure rate was higher among children < 15 years (14.5%) (p=0.03); however, no association was observed between ART outcomes and gender or route of transmission. The study suggests there are still some chances of virological and immunological failures despite the success of highly active ART (HAART). [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
17. The challenges and successes of implementing a sustainable antimicrobial resistance surveillance programme in Nepal.
- Author
-
Malla, Sarala, Dumre, Shyam Prakash, Shakya, Geeta, Kansakar, Palpasa, Rai, Bhupraj, Hossain, Anowar, Nair, Gopinath Balakrish, Albert, M John, Sack, David, Baker, Stephen, and Rahman, Motiur
- Abstract
Background: Antimicrobial resistance (AMR) is a major global public health concern and its surveillance is a fundamental tool for monitoring the development of AMR. In 1998, the Nepalese Ministry of Health (MOH) launched an Infectious Disease (ID) programme. The key components of the programme were to establish a surveillance programme for AMR and to develop awareness among physicians regarding AMR and rational drug usage in Nepal. Methods: An AMR surveillance programme was established and implemented by the Nepalese MOH in partnership with the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR, B) from 1998 to 2003. From 2004 to 2012, the programme was integrated and maintained as a core activity of the National Public Health Laboratory (NPHL) and resulted in an increased number of participating laboratories and pathogens brought under surveillance. The main strategies were to build national capacity on isolation, identification and AMR testing of bacterial pathogens, establish laboratory networking and an External Quality Assessment (EQA) programme, promote standardised recording and reporting of results, and to ensure timely analysis and dissemination of data for advocacy and national policy adaptations. The programme was initiated by nine participating laboratories performing AMR surveillance on Vibrio cholerae, Shigella spp., Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria gonorrhoeae. Results: The number of participating laboratories was ultimately increased to 13 and the number of pathogens under surveillance was increased to seven (Salmonella spp. was added to the surveillance programme in 2002 and extended spectrum β-lactamase producing Escherichia coli in 2011). From 1999 to 2012, data were available on 17,103 bacterial isolates. During the AMR programme, we observed changing trends in serovars/ species for Salmonella spp., Shigella spp. and V. cholerae and changing AMR trend for all organisms. Notably, N. gonorrhoeae isolates demonstrated increasing resistance to ciprofloxacin. Additionally, the performance of the participating laboratories improved as shown by annual EQA data evaluation. Conclusions: This Nepalese AMR programme continues and serves as a model for sustainable surveillance of AMR monitoring in resource limited settings. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
18. Short Report: Dengue Virus and Japanese Encephalitis Virus Epidemiological Shifts in Nepal: A Case of Opposing Trends.
- Author
-
Dumre, Shyam P., Shakya, Geeta, Na-Bangchang, Kesara, Eursitthichai, Veerachai, Grams, Hans Rudi, Upreti, Senendra R., Ghimire, Prakash, Khagendra, K. C., Nisalak, Ananda, Gibbons, Robert V., and Fernandez, Stefan
- Published
- 2013
- Full Text
- View/download PDF
19. Estimation of the Impact of a Japanese Encephalitis Immunization Program with Live, Attenuated SA 14-14-2 Vaccine in Nepal.
- Author
-
Upreti, Shyam Raj, Janusz, Kristen B., Shrestha, Sanjaya K., Hills, Susan L., Schluter, W. William, Bichha, Ram Padarath, Shakya, Geeta, Biggerstaff, Brad J., Shrestha, Murari Man, Sedai, Tika Ram, Fischer, Marc, and Gibbons, Robert V.
- Published
- 2013
- Full Text
- View/download PDF
20. The Spatial Heterogeneity between Japanese Encephalitis Incidence Distribution and Environmental Variables in Nepal.
- Author
-
Impoinvil, Daniel E., Solomon, Tom, Schluter, W. William, Rayamajhi, Ajit, Bichha, Ram Padarath, Shakya, Geeta, Caminade, Cyril, and Baylis, Matthew
- Subjects
JAPANESE encephalitis viruses ,VIRUS diseases ,DISEASE incidence ,VIRAL vaccines ,INFECTIOUS disease transmission ,EPIDEMIC encephalitis ,IMMUNIZATION - Abstract
Background: To identify potential environmental drivers of Japanese Encephalitis virus (JE) transmission in Nepal, we conducted an ecological study to determine the spatial association between 2005 Nepal JE incidence, and climate, agricultural, and land-cover variables at district level. Methods: District-level data on JE cases were examined using Local Indicators of Spatial Association (LISA) analysis to identify spatial clusters from 2004 to 2008 and 2005 data was used to fit a spatial lag regression model with climate, agriculture and land-cover variables. Results: Prior to 2006, there was a single large cluster of JE cases located in the Far-West and Mid-West terai regions of Nepal. After 2005, the distribution of JE cases in Nepal shifted with clusters found in the central hill areas. JE incidence during the 2005 epidemic had a stronger association with May mean monthly temperature and April mean monthly total precipitation compared to mean annual temperature and precipitation. A parsimonious spatial lag regression model revealed, 1) a significant negative relationship between JE incidence and April precipitation, 2) a significant positive relationship between JE incidence and percentage of irrigated land 3) a non-significant negative relationship between JE incidence and percentage of grassland cover, and 4) a unimodal non-significant relationship between JE Incidence and pigto- human ratio. Conclusion: JE cases clustered in the terai prior to 2006 where it seemed to shift to the Kathmandu region in subsequent years. The spatial pattern of JE cases during the 2005 epidemic in Nepal was significantly associated with low precipitation and the percentage of irrigated land. Despite the availability of an effective vaccine, it is still important to understand environmental drivers of JEV transmission since the enzootic cycle of JEV transmission is not likely to be totally interrupted. Understanding the spatial dynamics of JE risk factors may be useful in providing important information to the Nepal immunization program. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
21. Outbreak of pandemic influenza A/H1N1 2009 in Nepal.
- Author
-
Adhikari, Bal Ram, Shakya, Geeta, Upadhyay, Bishnu Prasad, Prakash, K. C. Khagendra, Shrestha, Sirjana Devi, and Dhungana, Guna Raj
- Subjects
- *
INFLUENZA A virus, H1N1 subtype , *PANDEMICS , *SWINE influenza , *PUBLIC health , *HEALTH & welfare funds - Abstract
Background: The 2009 flu pandemic is a global outbreak of a new strain of H1N1 influenza virus. Pandemic influenza A (H1N1) 2009 has posed a serious public health challenge world-wide. Nepal has started Laboratory diagnosis of Pandemic influenza A/H1N1 from mid June 2009 though active screening of febrile travellers with respiratory symptoms was started from April 27, 2009. Results: Out of 609 collected samples, 302 (49.6%) were Universal Influenza A positive. Among the influenza A positive samples, 172(28.3%) were positive for Pandemic influenza A/H1N1 and 130 (21.3%) were Seasonal influenza A. Most of the pandemic cases (53%) were found among young people with ≤ 20 years. Case Fatality Ratio for Pandemic influenza A/H1N1 in Nepal was 1.74%. Upon Molecular characterization, all the isolated pandemic influenza A/H1N1 2009 virus found in Nepal were antigenically and genetically related to the novel influenza A/CALIFORNIA/07/2009-LIKE (H1N1)v type. Conclusion: The Pandemic 2009 influenza virus found in Nepal were antigenically and genetically related to the novel A/CALIFORNIA/07/2009-LIKE (H1N1)v type. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
22. Low population Japanese encephalitis virus (JEV) seroprevalence in Udayapur district, Nepal, three years after a JE vaccination programme: A case for further catch up campaigns?
- Author
-
Turtle L, Brindle HE, Schluter WW, Faragher B, Rayamajhi A, Bohara R, Gurung S, Shakya G, Yoksan S, Dixit S, Rajbhandari R, Paudel B, Adhikari S, Solomon T, and Griffiths MJ
- Subjects
- Adult, Aged, Aged, 80 and over, Cross-Sectional Studies, Dengue Virus immunology, Enzyme-Linked Immunosorbent Assay, Female, Humans, Immunoglobulin G blood, Immunoglobulin M blood, Male, Middle Aged, Nepal epidemiology, Neutralization Tests, Seroepidemiologic Studies, Surveys and Questionnaires, Viral Plaque Assay, Young Adult, Antibodies, Neutralizing blood, Antibodies, Viral blood, Encephalitis Virus, Japanese immunology, Encephalitis, Japanese epidemiology, Encephalitis, Japanese prevention & control, Immunization Programs, Japanese Encephalitis Vaccines administration & dosage
- Abstract
The live attenuated Japanese encephalitis (JE) vaccine SA14-14-2 has been used in Nepal for catch-up campaigns and is now included in the routine immunisation schedule. Previous studies have shown good vaccine efficacy after one dose in districts with a high incidence of JE. The first well-documented dengue outbreak occurred in Nepal in 2006 with ongoing cases now thought to be secondary to migration from India. Previous infection with dengue virus (DENV) partially protects against JE and might also influence serum neutralising antibody titres against JEV. This study aimed to determine whether serum anti-JEV neutralisation titres are: 1. maintained over time since vaccination, 2. vary with historic local JE incidence, and 3. are associated with DENV neutralising antibody levels. We conducted a cross-sectional study in three districts of Nepal: Banke, Rupandehi and Udayapur. Udayapur district had been vaccinated against JE most recently (2009), but had been the focus of only one campaign, compared with two in Banke and three in Rupandehi. Participants answered a short questionnaire and serum was assayed for anti-JEV and anti-DENV IgM and IgG (by ELISA) and 50% plaque reduction neutralisation titres (PRNT50) against JEV and DENV serotypes 1-4. A titre of ≥1:10 was considered seropositive to the respective virus. JEV neutralising antibody seroprevalence (PRNT50 ≥ 1:10) was 81% in Banke and Rupandehi, but only 41% in Udayapur, despite this district being vaccinated more recently. Sensitivity of ELISA for both anti-JEV and anti-DENV antibodies was low compared with PRNT50. DENV neutralising antibody correlated with the JEV PRNT50 ≥1:10, though the effect was modest. IgM (indicating recent infection) against both viruses was detected in a small number of participants. We also show that DENV IgM is present in Nepali subjects who have not travelled to India, suggesting that DENV may have become established in Nepal. We therefore propose that further JE vaccine campaigns should be considered in Udayapur district, and similar areas that have had fewer vaccination campaigns., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2019
- Full Text
- View/download PDF
23. Genomic epidemiology of the Haitian cholera outbreak: a single introduction followed by rapid, extensive, and continued spread characterized the onset of the epidemic.
- Author
-
Eppinger M, Pearson T, Koenig SS, Pearson O, Hicks N, Agrawal S, Sanjar F, Galens K, Daugherty S, Crabtree J, Hendriksen RS, Price LB, Upadhyay BP, Shakya G, Fraser CM, Ravel J, and Keim PS
- Subjects
- Cholera transmission, Genotype, Haiti epidemiology, Molecular Epidemiology, Nepal, Phylogeography, Sequence Analysis, DNA, Vibrio cholerae O1 isolation & purification, Cholera epidemiology, Cholera microbiology, Epidemics, Genome, Bacterial, Molecular Typing, Vibrio cholerae O1 classification, Vibrio cholerae O1 genetics
- Abstract
Unlabelled: For centuries, cholera has been one of the most feared diseases. The causative agent Vibrio cholerae is a waterborne Gram-negative enteric pathogen eliciting a severe watery diarrheal disease. In October 2010, the seventh pandemic reached Haiti, a country that had not experienced cholera for more than a century. By using whole-genome sequence typing and mapping strategies of 116 serotype O1 strains from global sources, including 44 Haitian genomes, we present a detailed reconstructed evolutionary history of the seventh pandemic with a focus on the Haitian outbreak. We catalogued subtle genomic alterations at the nucleotide level in the genome core and architectural rearrangements from whole-genome map comparisons. Isolates closely related to the Haitian isolates caused several recent outbreaks in southern Asia. This study provides evidence for a single-source introduction of cholera from Nepal into Haiti followed by rapid, extensive, and continued clonal expansion. The phylogeographic patterns in both southern Asia and Haiti argue for the rapid dissemination of V. cholerae across the landscape necessitating real-time surveillance efforts to complement the whole-genome epidemiological analysis. As eradication efforts move forward, phylogeographic knowledge will be important for identifying persistent sources and monitoring success at regional levels. The results of molecular and epidemiological analyses of this outbreak suggest that an indigenous Haitian source of V. cholerae is unlikely and that an indigenous source has not contributed to the genomic evolution of this clade., Importance: In this genomic epidemiology study, we have applied high-resolution whole-genome-based sequence typing methodologies on a comprehensive set of genome sequences that have become available in the aftermath of the Haitian cholera epidemic. These sequence resources enabled us to reassess the degree of genomic heterogeneity within the Vibrio cholerae O1 serotype and to refine boundaries and evolutionary relationships. The established phylogenomic framework showed how outbreak isolates fit into the global phylogeographic patterns compared to a comprehensive globally and temporally diverse strain collection and provides strong molecular evidence that points to a nonindigenous source of the 2010 Haitian cholera outbreak and refines epidemiological standards used in outbreak investigations for outbreak inclusion/exclusion following the concept of genomic epidemiology. The generated phylogenomic data have major public health relevance in translating sequence-based information to assist in future diagnostic, epidemiological, surveillance, and forensic studies of cholera., (Copyright © 2014 Eppinger et al.)
- Published
- 2014
- Full Text
- View/download PDF
24. Dengue virus and Japanese encephalitis virus epidemiological shifts in Nepal: a case of opposing trends.
- Author
-
Dumre SP, Shakya G, Na-Bangchang K, Eursitthichai V, Rudi Grams H, Upreti SR, Ghimire P, KC K, Nisalak A, Gibbons RV, and Fernandez S
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Antibodies, Viral analysis, Child, Child, Preschool, Communicable Diseases, Emerging diagnosis, Communicable Diseases, Emerging epidemiology, Communicable Diseases, Emerging prevention & control, Communicable Diseases, Emerging virology, Cross Reactions, Dengue diagnosis, Dengue prevention & control, Dengue Vaccines administration & dosage, Disease Outbreaks prevention & control, Disease Outbreaks statistics & numerical data, Encephalitis, Japanese diagnosis, Encephalitis, Japanese prevention & control, Epidemiological Monitoring, Female, Humans, Japanese Encephalitis Vaccines administration & dosage, Male, Middle Aged, Nepal epidemiology, Vaccination, Young Adult, Dengue epidemiology, Dengue Virus pathogenicity, Encephalitis Virus, Japanese pathogenicity, Encephalitis, Japanese epidemiology
- Abstract
We report on the changing epidemiology of two important flaviviruses in Nepal: Japanese encephalitis (JE) and dengue viruses. Morbidity and mortality in Nepal is in the thousands since JE was introduced in 1978. Nepal launched an extensive laboratory-based JE surveillance in 2004. Nepal experienced a remarkable reduction in disease burden after mass immunizations from 2005 to 2010, when 2,040 JE infections and 205 JE-related deaths were confirmed. With its emergence in 2006, dengue has become a significant challenge in the country, highlighted by a sudden outbreak in 2010 that resulted in 359 confirmed dengue infections. Currently, both viruses cocirculate in Nepal. Here, we document the remarkable expansion of dengue in Nepal, which urgently requires national surveillance to refine the burden and make recommendations regarding control and prevention programs. We believe that the use of existing JE surveillance network for integrated dengue surveillance may represent the most appropriate alternative.
- Published
- 2013
- Full Text
- View/download PDF
25. Reply to "South Asia instead of Nepal may be the origin of the Haitian cholera outbreak strain".
- Author
-
Keim PS, Aarestrup FM, Shakya G, Price LB, Hendriksen RS, Engelthaler DM, and Pearson T
- Subjects
- Female, Humans, Male, Cholera epidemiology, Cholera microbiology, Genetic Variation, Vibrio cholerae genetics, Vibrio cholerae isolation & purification
- Published
- 2011
- Full Text
- View/download PDF
26. Population genetics of Vibrio cholerae from Nepal in 2010: evidence on the origin of the Haitian outbreak.
- Author
-
Hendriksen RS, Price LB, Schupp JM, Gillece JD, Kaas RS, Engelthaler DM, Bortolaia V, Pearson T, Waters AE, Upadhyay BP, Shrestha SD, Adhikari S, Shakya G, Keim PS, and Aarestrup FM
- Subjects
- Adolescent, Adult, Anti-Bacterial Agents pharmacology, Child, Disease Outbreaks, Female, Haiti epidemiology, Humans, Male, Middle Aged, Molecular Sequence Data, Nepal epidemiology, Phylogeny, Vibrio cholerae classification, Vibrio cholerae drug effects, Young Adult, Cholera epidemiology, Cholera microbiology, Genetic Variation, Vibrio cholerae genetics, Vibrio cholerae isolation & purification
- Abstract
Cholera continues to be an important cause of human infections, and outbreaks are often observed after natural disasters, such as the one following the 2010 earthquake in Haiti. Once the cholera outbreak was confirmed, rumors spread that the disease was brought to Haiti by a battalion of Nepalese soldiers serving as United Nations peacekeepers. This possible connection has never been confirmed. We used whole-genome sequence typing (WGST), pulsed-field gel electrophoresis (PFGE), and antimicrobial susceptibility testing to characterize 24 recent Vibrio cholerae isolates from Nepal and evaluate the suggested epidemiological link with the Haitian outbreak. The isolates were obtained from 30 July to 1 November 2010 from five different districts in Nepal. We compared the 24 genomes to 10 previously sequenced V. cholerae isolates, including 3 from the Haitian outbreak (began July 2010). Antimicrobial susceptibility and PFGE patterns were consistent with an epidemiological link between the isolates from Nepal and Haiti. WGST showed that all 24 V. cholerae isolates from Nepal belonged to a single monophyletic group that also contained isolates from Bangladesh and Haiti. The Nepalese isolates were divided into four closely related clusters. One cluster contained three Nepalese isolates and three Haitian isolates that were almost identical, with only 1- or 2-bp differences. Results in this study are consistent with Nepal as the origin of the Haitian outbreak. This highlights how rapidly infectious diseases might be transmitted globally through international travel and how public health officials need advanced molecular tools along with standard epidemiological analyses to quickly determine the sources of outbreaks.
- Published
- 2011
- Full Text
- View/download PDF
27. A growing global network's role in outbreak response: AFHSC-GEIS 2008-2009.
- Author
-
Johns MC, Burke RL, Vest KG, Fukuda M, Pavlin JA, Shrestha SK, Schnabel DC, Tobias S, Tjaden JA, Montgomery JM, Faix DJ, Duffy MR, Cooper MJ, Sanchez JL, Blazes DL, Wangchuk S, Dorji T, Gibbons R, Iamsirithaworn S, Richardson J, Buathong R, Jarman R, Yoon IK, Shakya G, Ofula V, Coldren R, Bulimo W, Sang R, Omariba D, Obura B, Mwala D, Kasper M, Brice G, Williams M, Yasuda C, Barthel RV, Pimentel G, Meyers C, Kammerer P, Baynes DE, Metzgar D, Hawksworth A, Blair P, Ellorin M, Coon R, Macintosh V, Burwell K, Macias E, Palys T, and Jerke K
- Subjects
- Communicable Disease Control organization & administration, Communicable Diseases, Emerging epidemiology, Communicable Diseases, Emerging prevention & control, Government Agencies, Humans, International Cooperation, Military Personnel, United States, World Health Organization, Communicable Disease Control methods, Disease Outbreaks prevention & control, Global Health, Sentinel Surveillance
- Abstract
A cornerstone of effective disease surveillance programs comprises the early identification of infectious threats and the subsequent rapid response to prevent further spread. Effectively identifying, tracking and responding to these threats is often difficult and requires international cooperation due to the rapidity with which diseases cross national borders and spread throughout the global community as a result of travel and migration by humans and animals. From Oct.1, 2008 to Sept. 30, 2009, the United States Department of Defense's (DoD) Armed Forces Health Surveillance Center Global Emerging Infections Surveillance and Response System (AFHSC-GEIS) identified 76 outbreaks in 53 countries. Emerging infectious disease outbreaks were identified by the global network and included a wide spectrum of support activities in collaboration with host country partners, several of which were in direct support of the World Health Organization's (WHO) International Health Regulations (IHR) (2005). The network also supported military forces around the world affected by the novel influenza A/H1N1 pandemic of 2009. With IHR (2005) as the guiding framework for action, the AFHSC-GEIS network of international partners and overseas research laboratories continues to develop into a far-reaching system for identifying, analyzing and responding to emerging disease threats.
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.